Is testosterone FDA-approved for women?

No. There is no testosterone product FDA-approved for women in the US as of 2026, though the FDA has given guidance on a pathway for a future female-specific product. Current use is off-label.

What are the side effects of testosterone in women?

The most common are acne, oily skin, and unwanted facial hair growth. Less common but more serious is voice deepening, which can be permanent. Side effects are dose-related, which is why monitoring matters.

Is testosterone safe long-term for women?

It appears reasonably safe at low, monitored doses over the one to two years most trials have studied, but multi-decade safety data, particularly for heart and breast health, does not yet exist. That is an honest evidence gap, not a confirmed risk.

Does testosterone help with energy or brain fog in perimenopause?

The trial evidence for energy, mood, and cognitive symptoms is weak and inconsistent, unlike the evidence for low sexual desire. Be skeptical of marketing that promises testosterone will fix these symptoms.

What the evidence actually says about testosterone for women

Written and edited by the Peryla team. Last reviewed August 2026. Educational information, not medical advice.

The evidence for testosterone in women is genuinely strong in one area, low sexual desire that causes distress (HSDD) after menopause, and much weaker everywhere else. Claims that testosterone reliably fixes energy, mood, brain fog, or weight are not well supported by controlled trials, even though they show up often in marketing.

Testosterone is also not risk-free. Side effects are usually mild and dose-related, but long-term safety data, especially for heart and breast health over many years, is still limited. That gap is a real reason to treat it as a deliberate decision, not a default add-on to HRT.

Where the evidence is strong: low sexual desire

Multiple randomized controlled trials, summarized in the 2019 Global Consensus Position Statement endorsed by more than a dozen international medical societies, found that testosterone modestly but consistently improves sexual desire, arousal, and satisfying sexual events in postmenopausal women with HSDD. This is the only indication with trial-level evidence solid enough that specialist societies formally recommend it.

Even here, the effect size is moderate, not dramatic, and it works best when other causes of low desire, such as relationship stress, depression, vaginal dryness, or other medications, have been addressed first.

Where the evidence is weak: energy, mood, cognition

For fatigue, mood, brain fog, or general wellbeing, trial evidence is inconsistent and mostly negative or inconclusive. Some small studies show a modest lift, others show no difference from placebo, and researchers who have reviewed the field have specifically cautioned against prescribing testosterone for these symptoms outside of research settings.

That gap between marketing claims and trial data is worth taking seriously, especially since some telehealth clinics promote testosterone broadly for 'low energy' or 'brain fog' without strong backing for those specific uses.

Known side effects

Side effects are generally dose-dependent, meaning they show up more with higher or male-range doses, which is exactly why correct, low, female dosing and monitoring matter.

Acne and oilier skin, among the most common early side effects.
Unwanted hair growth (hirsutism), particularly on the face.
Voice deepening, which can be irreversible if it occurs and dosing is not corrected quickly.
Effects on cholesterol (lipid) levels, which is one reason baseline and follow-up bloodwork matters.

What we still do not know

The honest gap is long-term data. Most trials run one to two years; there is not yet large-scale, multi-decade safety data on testosterone in women the way there is for estrogen therapy. A 2026 analysis specifically flagged rising prescribing alongside cardiovascular risk factors as a combination that needs closer study, not because harm has been proven, but because it has not been ruled out either.

That uncertainty is a reason for careful, monitored use with a prescriber, not a reason to avoid the conversation altogether if HSDD is genuinely affecting your life.

When to see a doctor

Before starting testosterone for anything other than diagnosed low sexual desire, so you understand what the evidence does and does not support.
If you develop acne, hair growth changes, or voice changes while using it.
If you have cardiovascular risk factors, since that is an active area of safety research.

Frequently asked questions

Is testosterone FDA-approved for women?: No. There is no testosterone product FDA-approved for women in the US as of 2026, though the FDA has given guidance on a pathway for a future female-specific product. Current use is off-label.
What are the side effects of testosterone in women?: The most common are acne, oily skin, and unwanted facial hair growth. Less common but more serious is voice deepening, which can be permanent. Side effects are dose-related, which is why monitoring matters.
Is testosterone safe long-term for women?: It appears reasonably safe at low, monitored doses over the one to two years most trials have studied, but multi-decade safety data, particularly for heart and breast health, does not yet exist. That is an honest evidence gap, not a confirmed risk.
Does testosterone help with energy or brain fog in perimenopause?: The trial evidence for energy, mood, and cognitive symptoms is weak and inconsistent, unlike the evidence for low sexual desire. Be skeptical of marketing that promises testosterone will fix these symptoms.